Blue Bees Therapeutics
Develops antibody-based immunotherapies for cancer, with an initial candidate targeting solid tumors
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Blue Bees Therapeutics
Blue Bees Therapeutics is a biotechnology company developing immunomodulatory antibodies for cancer treatment. Its lead candidate, BB101, is in regulatory preclinical development and is intended for solid tumors.
The company holds an exclusive worldwide license from CEA Paris-Saclay for the underlying technology. It is supported by SATT Paris-Saclay and has received early-stage financing through private equity and grants.
Founded in 2022, Blue Bees Therapeutics is headquartered in Orsay, France. It aims to begin a first-in-human trial of BB101 by mid-2028.
Product: Develops antibody-based immunotherapies, including BB101, an immunomodulatory candidate for solid tumors.
Jobs at Blue Bees Therapeutics
Leadership
- Michel Léonetti · Chief Scientific Officer*Source: company website
- Philippe Berthon · Chief Executive OfficerSource: company website
- Noëlle Couget · Chief Financial OfficerSource: company website
More biotech & pharma companies
Boiron
Homeopathic medicines and patient and practitioner services for consumers and healthcare professionals worldwideboiron.fr
French pharmaceutical company producing homeopathic medicines and health products for patients and healthcare professionalsNew on EvolcBrainever
Develops drug candidates for patients with neurodegenerative and retinal diseasesNew on EvolcBrenus Pharma
Off-the-shelf in vivo immunotherapies for solid tumors; lead programme targets metastatic colorectal cancerNew on EvolcByome Labs
Microbiome testing, consumer analysis and AI product matching for cosmetics, pharmaceutical and veterinary brands and laboratoriesYoung companyNew on EvolcCarbogen Amcis
Contract development and manufacturing of APIs and sterile drug products for pharmaceutical and biopharma companiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Content management
- WebnodeHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Site generatormeta generator
- Site generatormeta generator
- Site generatormeta generator
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.